Note: Ingredients listed on restricted chemical lists
EC/CAS
201-126-0/78-59-1
Name of the chemical
3,5,5-Trimethyl-2-cyclohexen-1-on
Concentration
>= 10 %
General Information
Product name
Iso-Phorone
CAS No.
78-59-1
1.2.1 Relevant identified uses
Laboratory chemicals, Industrial & for professional use only
Emergency telephone
+91 99921 51495
Icons in SDS
Company Information
company name
Bio-Chem Chemicals
e-mail address of the competent person responsible for the Safety Data Sheet
info@biofinechemical.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302+H312, H319, H335, H351
Hazard statements
Code
Statements
H302+H312
Harmful if swallowed or in contact with skin
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Warning
Hazard statements
H302 + H312 Harmful if swallowed or in contact with skin H319 Causes serious eye irritation. H335 May cause respiratory irritation. H351 Suspected of causing cancer.
Precautionary statements
P280 Wear protective gloves/ protective clothing. P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P302 + P352 + P312 IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/doctor if you feel unwell. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Supplemental label elements
none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 4), H302 Acute toxicity, Dermal (Category 4), H312 Eye irritation (Category 2), H319 Carcinogenicity (Category 2), H351 Specific target organ toxicity - single exposure (Category 3), Respiratory system, H335 For the full text of the H-Statements mentioned in this Section, see Section 16.
